Join to View Full Profile
300 Pasteur DrStanford University Medical Center Nuclear MedicinePalo Alto, CA 94305
Phone+1 650-723-6855
Dr. Davidzon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Guido Alejandro Davidzon is a Clinical Associate Professor of Nuclear Medicine and Molecular Imaging at the Stanford School of Medicine. He serves as the Director of Nuclear Cardiology at Stanford Health Care and is the Acting Chair of both the Clinical Radiation Safety Committee and the Radioactive Drug Research Committee.
Dr. Davidzon’s research focuses on advancing diagnostic and therapeutic approaches to improve clinical outcomes in prevalent diseases. His work emphasizes the clinical translation and evaluation of radioligands for applications in oncology, neurodegeneration, cardiology, and pain imaging, as well as the integration of machine learning techniques into clinical care.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Nuclear Medicine, 2010 - 2013
Massachusetts Institute of TechnologySM, Biomedical Informatics, 2008 - 2010
Massachusetts General Hospital2010
Yale-New Haven Medical CenterResidency, Surgery, 2006 - 2007
Maimonides University Faculty of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2011 - 2025
IL State Medical License 2013 - 2014
American Board of Nuclear Medicine Nuclear Medicine
Physician and Surgeon, Medical Board of California License A117782
Awards, Honors, & Recognition
- Best Essay Travel Grant Award SNM/ACNM Annual Meeting, 2012
- Young Investigator Award Symposium SNMMI, Nuclear Oncology Council, 2011
Clinical Trials
- Quantitative 13N-Ammonia Cardiac Rest/Stress Digital PET/CT Start of enrollment: 2017 Mar 29
- [18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers Start of enrollment: 2018 Apr 23
- Neuroimaging GABA Physiology in Fragile X Syndrome Start of enrollment: 2016 Nov 01
Publications & Presentations
PubMed
- 1 citationsPlasma Aβ/Aβis sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum.Alexandra N Trelle, Christina B Young, Hillary Vossler, Javier Ramos Benitez, Karly A Cody
Alzheimer's & Dementia. 2025-02-01 - Enhancing the Diagnostic Accuracy of Amyloid PET: The Impact of MR-Guided PET Reconstruction.M Mehdi Khalighi, Christina B Young, Skylar Weiss, Michael Zeineh, Guido Davidzon
Medrxiv. 2025-01-05 - F-PI-2620 Tau PET is associated with cognitive and motor impairment in Lewy body disease.Joseph R Winer, Hillary Vossler, Christina B Young, Viktorija Smith, America Romero
Brain Communications. 2025-01-01
Press Mentions
Stanford University Partners with Kheiron Medical Technologies to Pioneer Use of AI in New Areas of OncologyNovember 29th, 2021
Professional Memberships
- Member
- SNMMIMember
Other Languages
- Spanish
External Links
- Linkedinhttp://www.linkedin.com/in/gdavidzon/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
